跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPIDIOLEX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EPIDIOLEX
Authorized
STANDARD
EPIDIOLEX
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d7982b849692652a
Company
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Type
Standard
Approval Details
Approval Id
d7982b849692652a
Drug Approval Canada Name
EPIDIOLEX
Product Name
EPIDIOLEX
Status
Marketed
Status Date
2024-12-10
Original Market Date
2024-03-28
Din
02543079
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX24 CANNABIDIOL
Atc Name
n 03 ax 24
Aig Number
0165301001
Company Name
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Company Address
Building 730, Kent Science Park, Sittingbourne, Kent, United Kingdom, ME98AG
Company Detail Path
/organization/jazz-pharmaceuticals-research-uk-limited
Company Information
Pharmaceutical Company Name
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Country Name
United Kingdom
City Name
sittingbourne,country_gb
Address
Building 730
Active Ingredients
CANNABIDIOL
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d7982b849692652a
Type
Standard
Back to Health Canada Approvals